Oxford BioMedica PLC (LON:OXB)
628p+0.16%
Spriggl Score: Weak— see the number + sub-scores with a free Spriggl account
Last 30 trading days
Spriggl AI Verdict
“Gene therapy contract manufacturer turned its first profit; demanding growth targets are the only play.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Oxford BioMedica PLC
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems…
- Sector:
- Healthcare
- Industry:
- Biotechnology
- Market Cap:
- £753.3M
Recent dividends
No recent dividends recorded.
Get the full Spriggl analysis — free
Sign up for a free Spriggl account to unlock the full Spriggl Score breakdown, screener, watchlist, and AI investment analysis on Oxford BioMedica PLC and 1,600+ UK and US stocks.
Start free